Articul8, a spin-off from Intel, is raising $30-50 million to establish an India-based AI entity focused on traditional knowledge systems l...

Wockhardt's new antibiotic, Zaynich, has received US FDA approval. This drug uses a novel mechanism to fight drug-resistant bacteria. It ta...

Nilesh Shah, MD and CEO of Envision Capital, is buying through market volatility but steering clear of IT, questioning the validity of curr...

Tactical investing should not be confused with long-term investing. In a world where geopolitical risk, commodity shocks, and uncertainty a...

Amaravati, a new city in Andhra Pradesh, is becoming a hub for quantum computing. A technology park called Quantum Valley is attracting sci...

Kiran Mazumdar-Shaw has named her niece Claire Mazumdar as successor, setting up a gradual leadership transition at Biocon. A pioneer who b...

The ET Most Innovative AI Product Awards 2026 brings together 11 distinct categories that reflect where artificial intelligence is deliveri...

Amazon Web Services has launched Amazon Bio Discovery, an AI tool to accelerate drug discovery. Scientists can now generate and evaluate po...

Anthropic acquires startup Coefficient Bio for about $400 million: report

Companies such as Gilead, Eli Lilly and Regeneron have worked on novel treatments, either from their own labs or by reviving molecules that...

The duo showed how different strategies for inhibiting brakes on the immune system that can be used in cancer treatment.

Jubilant Chemsys, today announced an extension of collaborative partnership with Infectious Disease Research Institute (IDRI) for TB drug d...

Jubilant Chemsys, under the terms of agreement, so far had been offering philanthropic support and expertise in synthesis of NCEs to suppor...

The symposium is to address various aspects related to new drug discovery with a focus on cancer, inflammation, cardiometabolic diseases an...

"I feel very proud that I have proved world class research in the area of medicine can be done in India,"

Rising research and development initiatives in the pharma sector has made India a more mature place for drug discovery activities than Chin...

The new initiative named 'Grand Challenges Explorations' will support hundreds of early-stage research projects and will focus on large num...